New injection aims to save Insulin-Making cells in type 1 diabetes
NCT ID NCT06964087
First seen Nov 01, 2025 · Last updated Jun 11, 2026 · Updated 28 times
Summary
This study tests a new drug called OPT101 in adults diagnosed with type 1 diabetes within the last 20 years. Participants receive injections three times a week for up to one year. The goal is to see if OPT101 can safely help the body keep making its own insulin, reducing the need for injected insulin. The trial involves 72 people and compares different doses to a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE I DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Barbara Davis Center - University of Colorado Anschuttz Medical Campus
RECRUITINGAurora, Colorado, 80045, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Diablo Clinical Research Center
RECRUITINGWalnut Creek, California, 94598, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Rainier Clinical Research Center
RECRUITINGRenton, Washington, 98057, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Alabama at Birmingham - Department of Medicina
RECRUITINGBirmingham, Alabama, 35294, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Chicago Medical Center
RECRUITINGChicago, Illinois, 60637, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.